ArticleBritish journal of sports medicine2026
Outcomes of cardiac screening in elite para-football players in the United Kingdom.
Article in British journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cardiopulmonary Exercise Testing in the Differential Diagnosis Between Athlete's Heart and Cardiac Pathology: Current Evidence and Diagnostic Challenges.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesStudies to date have under-represented cardiac characteristics of para athletes, despite their unique cardiovascular physiology and risks. This study examined the cardiac electrical and structural characteristics and outcomes of pre-participation cardiac screening in elite para-football players.
methodsBetween 2011 and 2024, 156 consecutive para-football players underwent pre-participation evaluation comprising a health questionnaire, 12-lead ECG and echocardiogram. Players with symptoms or abnormal preliminary investigations were evaluated further, including exercise testing and cardiac MRI. Findings were compared with 1000 consecutive sex-matched and ethnicity-matched non-para-football players. Mean follow-up was 4.7±3.1 years.
resultsThe mean age of para-football players was 21.2±5.2 years. The majority were male (71.2%) and white ethnicity (84%), followed by mixed-race (7.1%), Asian (4.5%) and Afro-Caribbean (3.8%) ethnicity. Para-football players reported cardiac symptoms more frequently and required more follow-up than non-para players (14.7% vs 6.6%; p=0.001). Para players demonstrated less sinus bradycardia (35.3% vs 44.5%; p=0.037) and a similar prevalence of abnormal T-wave inversion (1.9% vs 3.0%; p=0.622). A short PR interval was observed in 4.5% of para players compared with 0.5% of non-para players (p<0.001), although QTc intervals were similar between the two groups (402±24 ms vs 399±19 ms; p=0.138). Four (2.6%) para-football players received diagnoses associated with sudden cardiac death (SCD) versus three (0.3%) non-para players (p=0.005). Six (3.8%) para-football players were diagnosed with minor cardiovascular conditions versus 1.8% non-para players (p=0.17). In total, 10 (6.4%) para-football players were diagnosed with cardiac pathology versus 21 (2.1%) non-para-football players (p=0.005), all of whom required management or were kept under surveillance. No SCD events occurred over 4.7±3.1 years of follow-up in para-football players.
conclusionIn this study, para-football players were three times more likely to be diagnosed with a cardiac condition requiring management and/or surveillance compared with non-para players. Moreover, para-football players had a higher prevalence of serious cardiac disease associated with SCD. Cardiac screening inclusive of ECG is warranted in this growing cohort of athletes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.